Breaking News
May 3, 2019 - Vaping and Smoking May Signal Greater Motivation to Quit
May 3, 2019 - Dementia looks different in brains of Hispanics
May 3, 2019 - Short-Staffed Nursing Homes See Drop In Medicare Ratings
May 3, 2019 - Study of teens with eating disorders explores how substance users differ from non-substance users
May 3, 2019 - Scientists develop new video game that may help in the study of Alzheimer’s
May 3, 2019 - Arc Bio introduces Galileo Pathogen Solution product line at ASM Clinical Virology Symposium
May 3, 2019 - Cornell University study uncovers relationship between starch digestion gene and gut bacteria
May 3, 2019 - How to Safely Use Glucose Meters and Test Strips for Diabetes
May 3, 2019 - Anti-inflammatory drugs ineffective for prevention of Alzheimer’s disease
May 3, 2019 - Study tracks Pennsylvania’s oil and gas waste-disposal practices
May 3, 2019 - Creating a better radiation diagnostic test for astronauts
May 3, 2019 - Vegans are often deficient in these four nutrients
May 3, 2019 - PPDC announces seed grants to develop medical devices for children
May 3, 2019 - Study maps out the frequency and impact of water polo head injuries
May 3, 2019 - Research on Reddit identifies risks associated with unproven treatments for opioid addiction
May 3, 2019 - Good smells may help ease tobacco cravings
May 3, 2019 - Medical financial hardship found to be very common among people in the United States
May 3, 2019 - Researchers develop multimodal system for personalized post-stroke rehabilitation
May 3, 2019 - Study shows significant mortality benefit with CABG over percutaneous coronary intervention
May 3, 2019 - Will gene-editing of human embryos ever be justifiable?
May 3, 2019 - FDA Approves Dengvaxia (dengue vaccine) for the Prevention of Dengue Disease in Endemic Regions
May 3, 2019 - Why Tonsillitis Keeps Coming Back
May 3, 2019 - Fighting the opioid epidemic with data
May 3, 2019 - Maggot sausages may soon be a reality
May 3, 2019 - Deletion of ATDC gene prevents development of pancreatic cancer in mice
May 2, 2019 - Targeted Therapy Promising for Rare Hematologic Cancer
May 2, 2019 - Alzheimer’s disease is a ‘double-prion disorder,’ study shows
May 2, 2019 - Reservoir bugs: How one bacterial menace makes its home in the human stomach
May 2, 2019 - Clinical, Admin Staff From Cardiology Get Sneak Peek at Epic
May 2, 2019 - Depression increases hospital use and mortality in children
May 2, 2019 - Vicon and NOC support CURE International to create first gait lab in Ethiopia
May 2, 2019 - Researchers use 3D printer to make paper organs
May 2, 2019 - Viral infection in utero associated with behavioral abnormalities in offspring
May 2, 2019 - U.S. Teen Opioid Deaths Soaring
May 2, 2019 - Opioid distribution data should be public
May 2, 2019 - In the Spotlight: “I’m learning every single day”
May 2, 2019 - 2019 Schaefer Scholars Announced
May 2, 2019 - Podcast: KHN’s ‘What The Health?’ Bye-Bye, ACA, And Hello ‘Medicare-For-All’?
May 2, 2019 - Study describes new viral molecular evasion mechanism used by cytomegalovirus
May 2, 2019 - SLU study suggests a more equitable way for Medicare reimbursement
May 2, 2019 - Scientists discover first gene involved in lower urinary tract obstruction
May 2, 2019 - Researchers identify 34 genes associated with increased risk of ovarian cancer
May 2, 2019 - Many low-income infants receive formula in the first few days of life, finds study
May 2, 2019 - Global study finds high success rate for hip and knee replacements
May 2, 2019 - Taking depression seriously: What is it?
May 2, 2019 - With Head Injuries Mounting, Will Cities Put Their Feet Down On E-Scooters?
May 2, 2019 - Scientists develop small fluorophores for tracking metabolites in living cells
May 2, 2019 - Study casts new light into how mothers’ and babies’ genes influence birth weight
May 2, 2019 - Researchers uncover new brain mechanisms regulating body weight
May 2, 2019 - Organ-on-chip systems offered to Asia-Pacific regions by Sydney’s AXT
May 2, 2019 - Adoption of new rules drops readmission penalties against safety net hospitals
May 2, 2019 - Kids and teens who consume zero-calorie sweetened beverages do not save calories
May 2, 2019 - Improved procedure for cancer-related erectile dysfunction
May 2, 2019 - Hormone may improve social behavior in autism
May 2, 2019 - Alzheimer’s disease may be caused by infectious proteins called prions
May 2, 2019 - Even Doctors Can’t Navigate Our ‘Broken Health Care System’
May 2, 2019 - Study looks at the impact on criminal persistence of head injuries
May 2, 2019 - Honey ‘as high in sugars as table sugar’
May 2, 2019 - Innovations to U.S. food system could help consumers in choosing healthy foods
May 2, 2019 - FDA Approves Mavyret (glecaprevir and pibrentasvir) as First Treatment for All Genotypes of Hepatitis C in Pediatric Patients
May 2, 2019 - Women underreport prevalence and intensity of their own snoring
May 2, 2019 - Concussion summit focuses on science behind brain injury
May 2, 2019 - Booker’s Argument For Environmental Justice Stays Within The Lines
May 2, 2019 - Cornell research explains increased metastatic cancer risk in diabetics
May 2, 2019 - Mount Sinai study provides fresh insights into cellular pathways that cause cancer
May 2, 2019 - Researchers to study link between prenatal pesticide exposures and childhood ADHD
May 2, 2019 - CoGEN Congress 2019: Speakers’ overviews
May 2, 2019 - A new strategy for managing diabetic macular edema in people with good vision
May 2, 2019 - Sagent Pharmaceuticals Issues Voluntary Nationwide Recall of Ketorolac Tromethamine Injection, USP, 60mg/2mL (30mg per mL) Due to Lack of Sterility Assurance
May 2, 2019 - Screen time associated with behavioral problems in preschoolers
May 2, 2019 - Hormone reduces social impairment in kids with autism | News Center
May 2, 2019 - Researchers synthesize peroxidase-mimicking nanozyme with low cost and superior catalytic activity
May 2, 2019 - Study results of a potential drug to treat Type 2 diabetes in children announced
May 2, 2019 - Multigene test helps doctors to make effective treatment decisions for breast cancer patients
May 2, 2019 - UNC School of Medicine initiative providing unique care to dementia patients
May 2, 2019 - Nestlé Health Science and VHP join forces to launch innovative COPES program for cancer patients
May 2, 2019 - Study examines how our brain generates consciousness and loses it during anesthesia
May 2, 2019 - Transition Support Program May Aid Young Adults With Type 1 Diabetes
May 2, 2019 - Study shows how neutrophils exacerbate atherosclerosis by inducing smooth muscle-cell death
May 2, 2019 - Research reveals complexity of how we make decisions
Cancer cells could be detected irrespective of site and type using simple test

Cancer cells could be detected irrespective of site and type using simple test

Australian researchers have found that cells containing cancer could soon be detected using a simple test. The test could one day change how cancers are diagnosed, the team says. The results of the study to develop the test were published in the journal Nature Communications.

Cancer cells in their early stages have certain DNA signatures, the team noted that make them unique. They said that the DNA from different types of cancers contain signatures which could act as cancer markers. They add that the team is developing the test so that it could be used for screening of cancers especially in early stages.

Researchers at the University of Queensland have developed a simple test to see if there are DNA changes in the cells from blood and biopsy tissue. Matt Trau, one of the researchers, said that it was difficult to find a “simple marker” that could differentiate between cancer cells and healthy cells. He said, “We never thought this would be possible, because cancer is so complicated.” He said that they initially believed that each cancer would need a separate test for detection. The team then noted that this novel marker was present in all types of breast cancer, colorectal or bowel cancer, prostate cancer and lymphomas.

Prof Trau said the results “stunned” them and they realized that this was a “general feature for all cancer.” Trau explained that they relied on epigenetics and found that there were changes in the DNA that could control the functions of the cells. “Usually, the approach to find cancer markers … is to look at the sequence of DNA,” he explained. For this test, he said, they looked at patterns of methyl groups over the DNA. These groups act as switches that switch the genes on and off and are called epigenomes. They are instructions that control the expressions of the genes.

The team found that in the healthy cells these methyl groups are spread across the genome. Among the cancer cells they noted that the methyl groups are in clusters at specific regions. Trau said, “Virtually every piece of cancerous DNA we examined had this highly predictable pattern… If you think of a cell as a hard-drive … the epigenome is sort of like the apps the cell is running at any one moment. It seems that to launch cancer, you have to run a series of genetic apps.” The test would help the scientists detect the cancer cells by identifying these patterns of spread of the methyl groups or the epigenetic patterns.

The team used cancerous DNA molecules and placed it in a chemical solution that let it to fold in complex 3D structures. These complex structures depending upon the epigenetic pattern would then stick to gold nanoparticles used for the test. This changes the colour of the solution containing the nanoparticles and this change can be detected with the “naked eye” said Trau. The team tested the test on 200 samples of cancer cells and found that the test was accurate in 90 percent cases. The test however can detect only the presence of the cancer and not the site of the cancer, stage of the cancer or the type of the cancer.

Gold nanoparticles produced by laser ablation in heavy water. Scale bar denotes twenty nanometers (20 nm). Image Credit: Georgy Shafeev / Shutterstock

Gold nanoparticles produced by laser ablation in heavy water. Scale bar denotes twenty nanometers (20 nm). Image Credit: Georgy Shafeev / Shutterstock

“A major advantage of this technique is that it is very cheap and extremely simple to do, so it could be adopted in the clinic quite easily,” said Laura Carrascosa, a researcher at the University of Queensland. She said, “Our technique could be a screening tool to inform clinicians that a patient may have a cancer, but they would require subsequent tests with other techniques to identify the cancer type and stage.”

The study was funded by the National Breast Cancer Foundation and was supported by University of Queensland’s commercialisation company UniQuest which is helping develop the technology. Professor Trau said that the next step would be to start clinical trials to hone the test. “We certainly don’t know yet whether it’s the holy grail for all cancer diagnostics, but it looks really interesting,” he concluded.

Source:

https://www.nature.com/articles/s41467-018-07214-w

Tagged with:

About author

Related Articles